This helps curb hunger and reduce the desire to overeat, which is why GLP-1 medications are used in medical weight loss treatments
While most people can safely take Wegovy or Ozempic, you should avoid these medications if you have severe gastroparesis (stomach paralysis)
Three semaglutide medications are currently approved by the FDA: Wegovy is approved for weight loss treatment, and can be prescribed to adults and children 12 and older with obesity, as well as some adults with overweight who also have weight-related health problems, such as high blood pressure
GLP-1/GIP Tirzepatide Studied for weight management in appropriate patients
Eating high fiber foods like oats, lentils, and vegetables supports the gut bacteria that produce short-chain fatty acids, a direct trigger for GLP-1 secretion
The SURMOUNT-4 trial assessed the weight maintenance with tirzepatide and had also two periods: a 36-week open-label lead-in period during which all participants took tirzepatide, followed by a 52-week double-blind treatment period during which participants were randomised to either continue on tirzepatide or switch to placebo